Prognostic Significance of Small-Artery Structure in Hypertension

Circulation

Volumn 108, Issue 18, 2003, Pages 2230-2235

  Rizzoni, Damiano ^b   Porteri, Enzo ^b   Boari, Gianluca E M ^b   De Ciuceis, Carolina ^b   Sleiman, Intissar ^b   Muiesan, Maria Lorenza ^b   Castellano, Maurizio ^b   Miclini, Marco ^b   Agabiti Rosei, Enrico ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b NONE

Author keywords

Arteries; Hypertension; Prognosis; Remodeling; Vessels

Indexed keywords

ADULT; AGED; ARTERY DIAMETER; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MYOGRAPHY; PHEOCHROMOCYTOMA; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROGNOSIS; PULSE PRESSURE; RENOVASCULAR HYPERTENSION; RESISTANCE BLOOD VESSEL; RISK FACTOR; SUBCUTANEOUS FAT;

ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; ARTERIOLES; BIOPSY; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; HYPERTENSION, RENAL; MALE; MIDDLE AGED; MYOGRAPHY; PHEOCHROMOCYTOMA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REFERENCE VALUES; SUBCUTANEOUS TISSUE; VASCULAR PATENCY;

EID: 0242330196     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000095031.51492.C5     Document Type: Article

References (36)

1. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev. 1990;70:921-961.
2. Levy BI, Ambrosio G, Pries AR, et al. Microcirculation in hypertension: a new target for treatment? Circulation. 2001;104:735-740.
3. Borders JL, Granger HJ. Power dissipation as a measure of peripheral resistance in vascular networks. Hypertension. 1986;8:184-191.
4. Bohlen HG. Localization of vascular resistance changes during hypertension. Hypertension. 1986;8:181-183.
5. Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 1982;62:347-504.
6. Aalkjaer C, Haegerty AM, Petersen KK, et al. Evidence for increased media thickness, increased neural amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res. 1987;61:181-186.
7. Aalkjaer C, Eiskjaer H, Mulvany MJ, et al. Abnormal structure and function of isolated subcutaneous resistance vessels from essential hypertensive patients despite antihypertensive treatment. J Hypertens. 1989;7:305-310.
8. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens. 1999;17:151-183.
9. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-1201.
10. Sahn DJ, De Maria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083.
11. Muiesan ML, Pasini GF, Salvetti M, et al. Cardiac and vascular structural changes: prevalence and relation to ambulatory blood pressure in a middle-aged general population in northern Italy: the Vobarno Study. Hypertension. 1996;27:1046-1052.
12. Mulvany MJ, Halpern W. Contractile properties of small resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977;41:19-26.
13. Mulvany MJ, Hansen PK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res. 1978;43:854-864.
14. Rizzoni D, Porteri E, Castellano M, et al. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension. 1996;28:785-790.
15. Agabiti-Rosei E, Rizzoni D, Castellano M, et al. Media:lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertens. 1995;13:341-347.
16. Lee RT, Berditchevski F, Cheng GC, et al. Integrin-mediated collagen matrix reorganization by cultured human vascular smooth muscle cells. Circ Res. 1995;76:209-214.
17. Mulvany MJ. Resistance vessel growth and remodelling: cause or consequence in cardiovascular disease. J Human Hypertens. 1995;9:479-485.
18. Lever AF. Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels? J Hypertens. 1986;4:515-524.
19. Korner PI, Bobik A, Jennings GL, et al. Significance of cardiovascular hypertrophy in the development and maintenance of hypertension. J Cardiovasc Pharmacol. 1991;17(suppl 2):S25-S32.
20. Schiffrin EL. Reactivity of small blood vessel in hypertension: relation with structural changes. Hypertension. 1992;19(suppl II):II-1-II-9.
21. Izzard AS, Heagerty AM, Leenen FHH. The amplifier hypothesis: permission to dissent? J Hypertens. 1999;17:1667-1669.
22. Izzard AS, Heagerty AM, Leenen FH. The amplifier hypothesis: persisting dissent. J Hypertens. 2002;20:375-377.
23. Rizzoni D, Palombo C, Porteri E, et al. Relationships between coronary vasodilator capacity and small artery remodeling in hypertensive patients. J Hypertens. 2003;21:625-632.
24. Rizzoni D, Porteri E, Guelfi D, et al. Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus. Circulation. 2001;103:1238-1244.
25. Park JB, Schiffrin EL. Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension. J Hypertens. 2001;19:921-930.
26. Muiesan ML, Rizzoni D, Salvetti M, et al. Structural changes in small resistance arteries and left ventricular geometry in patients with primary and secondary hypertension. J Hypertens. 2002;20:1439-1444.
27. Schiffrin EL, Deng LY, Larochelle P. Effects of a β-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension. 1994;23:83-91.
28. Rizzoni D, Muiesan ML, Porteri E, et al. Effect of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy. J Hypertens. 1997;15:197-204.
29. Schiffrin EL, Park JB, Integan HD, et al. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonists losartan. Circulation. 2000;101:1653-1659.
30. Schiffrin EL, Deng LY. Structure and function of resistance arteries of hypertensive patients treated with a beta blocker or a calcium channel antagonist. J Hypertens. 1996;14:1237-1244.
31. Neild TO, Attal J, Saurel JM. Images of arterioles in unfixed tissue obtained by acoustic microscopy. J Microscopy. 1995;139(pt 1):19-25.
32. Briggs GA, Wang J, Gundle R. Quantitative acoustic microscopy of individual living human cells. J Microscopy. 1993;172(pt 1):3-12.
33. Arribas SM, Hillier C, Gonzalez C, et al. Cellular aspects of vascular remodeling in hypertension revealed by confocal microscopy. Hypertension. 1997;36:1455-1464.
34. King RG, Delaney M. Confocal microscopy in pharmacological research. Trends Pharmacol Sci. 1994;15:275-279.
35. Masters BR, So PTC, Gratton E. Multiphoton excitation fluorescence microscopy and spectroscopy of in vivo human skin. Biophys J. 1997;72:2405-2412.
36. Pries AR, Secomb TW, Gaehtgens P. Structural autoregulation of terminal vascular beds: vascular adaptation and development of hypertension. Hypertension. 1999;33:153-161.